Degradation of the Alzheimer ß-amyloid 1-40 peptide by a new metalloendopeptidase A new brain metalloendopeptidase which degrades the Alzheimer ß-amy-loid 1-40 peptide producing soluble fragments without neurotoxic effect
In Alzheimer’s disease (AD), the expression of matrix metallo-proteases (MMPs), which are capable of...
Alzheimer's disease is a debilitating neurological disease placing significant burden on health care...
Background Aggregation of the amyloid-β (Aβ) peptide in the brain is one of the key pathological eve...
A new metalloendopeptidase was purified to apparent homogeneity from a homogenate of normal human br...
Alzheimer's disease is a neurodegenerative condition characterized by an accumulation of toxic amylo...
Proteolytic enzymes constitute around 2% of the human genome and are involved in many stages of cell...
The abnormal accumulation of amyloid-beta peptide is believed to cause malfunctioning of neurons in ...
BACKGROUND The abnormal accumulation of amyloid-beta peptide is believed to cause malfunctioning of...
Amyloid p peptide (Ap) is a physiological peptide that is constantly catabolized in the brain. We pr...
Les plaques séniles sont des dépôts fibrillaires extracellulaires associées à la maladie d'Alzheimer...
Insulin degrading enzyme (IDE) is a metalloprotease that has been involved in amyloid beta peptide (...
Deposition of amyloid-beta peptide (Abeta) in the brain is an early and invariant feature of all for...
Compelling evidence suggests a crucial role of amyloid beta peptides (Aβ(1-40/42)) in the etiology o...
Alzheimer’s disease is characterised by progressive loss of memory and cognitive functions. The symp...
Amyloid beta peptide implicated in Alzheimers disease is cleaved by insulin degrading enzyme (IDE). ...
In Alzheimer’s disease (AD), the expression of matrix metallo-proteases (MMPs), which are capable of...
Alzheimer's disease is a debilitating neurological disease placing significant burden on health care...
Background Aggregation of the amyloid-β (Aβ) peptide in the brain is one of the key pathological eve...
A new metalloendopeptidase was purified to apparent homogeneity from a homogenate of normal human br...
Alzheimer's disease is a neurodegenerative condition characterized by an accumulation of toxic amylo...
Proteolytic enzymes constitute around 2% of the human genome and are involved in many stages of cell...
The abnormal accumulation of amyloid-beta peptide is believed to cause malfunctioning of neurons in ...
BACKGROUND The abnormal accumulation of amyloid-beta peptide is believed to cause malfunctioning of...
Amyloid p peptide (Ap) is a physiological peptide that is constantly catabolized in the brain. We pr...
Les plaques séniles sont des dépôts fibrillaires extracellulaires associées à la maladie d'Alzheimer...
Insulin degrading enzyme (IDE) is a metalloprotease that has been involved in amyloid beta peptide (...
Deposition of amyloid-beta peptide (Abeta) in the brain is an early and invariant feature of all for...
Compelling evidence suggests a crucial role of amyloid beta peptides (Aβ(1-40/42)) in the etiology o...
Alzheimer’s disease is characterised by progressive loss of memory and cognitive functions. The symp...
Amyloid beta peptide implicated in Alzheimers disease is cleaved by insulin degrading enzyme (IDE). ...
In Alzheimer’s disease (AD), the expression of matrix metallo-proteases (MMPs), which are capable of...
Alzheimer's disease is a debilitating neurological disease placing significant burden on health care...
Background Aggregation of the amyloid-β (Aβ) peptide in the brain is one of the key pathological eve...